State Street’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $102K | Buy |
426,714
+5,422
| +1% | +$1.3K | ﹤0.01% | 3971 |
|
|
2025
Q1 | $83K | Buy |
421,292
+21,213
| +5% | +$4.18K | ﹤0.01% | 4007 |
|
|
2024
Q4 | $216K | Buy |
400,079
+3,287
| +0.8% | +$1.77K | ﹤0.01% | 3837 |
|
|
2024
Q3 | $377K | Buy |
396,792
+5,891
| +2% | +$5.6K | ﹤0.01% | 3650 |
|
|
2024
Q2 | $381K | Buy |
390,901
+78,363
| +25% | +$76.4K | ﹤0.01% | 3623 |
|
|
2024
Q1 | $494K | Buy |
312,538
+7,202
| +2% | +$11.4K | ﹤0.01% | 3652 |
|
|
2023
Q4 | $242K | Buy |
305,336
+6,235
| +2% | +$4.94K | ﹤0.01% | 3851 |
|
|
2023
Q3 | $233K | Buy |
299,101
+8,127
| +3% | +$6.34K | ﹤0.01% | 3894 |
|
|
2023
Q2 | $269K | Buy |
290,974
+6,233
| +2% | +$5.77K | ﹤0.01% | 3916 |
|
|
2023
Q1 | $310K | Buy |
284,741
+15,943
| +6% | +$17.4K | ﹤0.01% | 3912 |
|
|
2022
Q4 | $392K | Sell |
268,798
-40,500
| -13% | -$59.1K | ﹤0.01% | 3853 |
|
|
2022
Q3 | $332K | Sell |
309,298
-57,227
| -16% | -$61.4K | ﹤0.01% | 3928 |
|
|
2022
Q2 | $623K | Sell |
366,525
-274,095
| -43% | -$466K | ﹤0.01% | 3751 |
|
|
2022
Q1 | $1.32M | Buy |
640,620
+25,627
| +4% | +$52.8K | ﹤0.01% | 3719 |
|
|
2021
Q4 | $2.31M | Buy |
614,993
+47,784
| +8% | +$179K | ﹤0.01% | 3594 |
|
|
2021
Q3 | $2.94M | Buy |
567,209
+307,627
| +119% | +$1.6M | ﹤0.01% | 3501 |
|
|
2021
Q2 | $1.11M | Sell |
259,582
-147,905
| -36% | -$630K | ﹤0.01% | 3649 |
|
|
2021
Q1 | $2.16M | Buy |
407,487
+47,014
| +13% | +$250K | ﹤0.01% | 3411 |
|
|
2020
Q4 | $1.94M | Buy |
360,473
+154,691
| +75% | +$834K | ﹤0.01% | 3390 |
|
|
2020
Q3 | $1.64M | Buy |
205,782
+33,551
| +19% | +$268K | ﹤0.01% | 3278 |
|
|
2020
Q2 | $1.72M | Buy |
+172,231
| New | +$1.72M | ﹤0.01% | 3238 |
|
|
2019
Q3 | – | Sell |
-38,434
| Closed | -$155K | – | 3806 |
|
|
2019
Q2 | $155K | Sell |
38,434
-1,019
| -3% | -$4.11K | ﹤0.01% | 3627 |
|
|
2019
Q1 | $170K | Sell |
39,453
-1,170
| -3% | -$5.04K | ﹤0.01% | 3590 |
|
|
2018
Q4 | $234K | Buy |
40,623
+4,350
| +12% | +$25.1K | ﹤0.01% | 3550 |
|
|
2018
Q3 | $492K | Hold |
36,273
| – | – | ﹤0.01% | 3483 |
|
|
2018
Q2 | $431K | Sell |
36,273
-1,480
| -4% | -$17.6K | ﹤0.01% | 3487 |
|
|
2018
Q1 | $424K | Sell |
37,753
-63,626
| -63% | -$715K | ﹤0.01% | 3452 |
|
|
2017
Q4 | $678K | Sell |
101,379
-821
| -0.8% | -$5.49K | ﹤0.01% | 3411 |
|
|
2017
Q3 | $837K | Buy |
102,200
+36,400
| +55% | +$298K | ﹤0.01% | 3410 |
|
|
2017
Q2 | $295K | Hold |
65,800
| – | – | ﹤0.01% | 3500 |
|
|
2017
Q1 | $363K | Hold |
65,800
| – | – | ﹤0.01% | 3429 |
|
|
2016
Q4 | $266K | Hold |
65,800
| – | – | ﹤0.01% | 3469 |
|
|
2016
Q3 | $464K | Hold |
65,800
| – | – | ﹤0.01% | 3302 |
|
|
2016
Q2 | $536K | Hold |
65,800
| – | – | ﹤0.01% | 3381 |
|
|
2016
Q1 | $535K | Hold |
65,800
| – | – | ﹤0.01% | 3339 |
|
|
2015
Q4 | $794K | Buy |
+65,800
| New | +$794K | ﹤0.01% | 3257 |
|